Read + Share
Amedeo Smart
Independent Medical Education
Chappuis M, Rousseau C, Bajeux E, Wiertlewski S, et al. Discontinuation of second- versus first-line disease-modifying treatment in middle-aged patients with multiple sclerosis. J Neurol 2022 Sep 16. pii: 10.1007/s00415-022-11341.PMID: 36121558
Email
LinkedIn
Facebook
Twitter
Privacy Policy